Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV
Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopin...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/391 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849244584472739840 |
|---|---|
| author | V. N. Shchukina S. Ya. Loginova S. V. Borisevich V. P. Bondarev |
| author_facet | V. N. Shchukina S. Ya. Loginova S. V. Borisevich V. P. Bondarev |
| author_sort | V. N. Shchukina |
| collection | DOAJ |
| description | Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual. |
| format | Article |
| id | doaj-art-0c16e8d1224f4af6985ee82061cf6e23 |
| institution | Kabale University |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2020-05-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-0c16e8d1224f4af6985ee82061cf6e232025-08-20T03:59:08ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01567-84246390Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IVV. N. Shchukina0S. Ya. Loginova1S. V. Borisevich2V. P. Bondarev3Филиал федерального государственного учреждения «48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации - «Вирусологический центр»Филиал федерального государственного учреждения «48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации - «Вирусологический центр»Филиал федерального государственного учреждения «48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации - «Вирусологический центр»Филиал федерального государственного учреждения «48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации - «Вирусологический центр»Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual.https://www.antibiotics-chemotherapy.ru/jour/article/view/391severe acute respiratory syndromeantiviral activitycoronavirus infectionchemotherapyribavirinlopinavirritonavir |
| spellingShingle | V. N. Shchukina S. Ya. Loginova S. V. Borisevich V. P. Bondarev Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV Антибиотики и Химиотерапия severe acute respiratory syndrome antiviral activity coronavirus infection chemotherapy ribavirin lopinavir ritonavir |
| title | Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV |
| title_full | Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV |
| title_fullStr | Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV |
| title_full_unstemmed | Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV |
| title_short | Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV |
| title_sort | experience with empirical treatment of severe acute respiratory syndrome due to coronavirus genotype iv |
| topic | severe acute respiratory syndrome antiviral activity coronavirus infection chemotherapy ribavirin lopinavir ritonavir |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/391 |
| work_keys_str_mv | AT vnshchukina experiencewithempiricaltreatmentofsevereacuterespiratorysyndromeduetocoronavirusgenotypeiv AT syaloginova experiencewithempiricaltreatmentofsevereacuterespiratorysyndromeduetocoronavirusgenotypeiv AT svborisevich experiencewithempiricaltreatmentofsevereacuterespiratorysyndromeduetocoronavirusgenotypeiv AT vpbondarev experiencewithempiricaltreatmentofsevereacuterespiratorysyndromeduetocoronavirusgenotypeiv |